This could indirectly suggest that DPP-4 inhibitors may be less effective in pasireotide-induced hyperglycemia
Altun, D
"As use of this medication is extended and expanded for weight loss and other health advocacy, there is an opportunity to do much more, including product development, packaging, online and in-store merchandising, education, and promotion." Opportunities include: Merchandise dietary and nutritional support items near the pharmacy in drug and grocery, improving the shopping experience for consumers taking GLP-1s Understand that 91% of Millennials, 90% of Gen Z, and 64% of Gen X on GLP-1 medications are interested in packaged foods that support their weight loss goals, and they want messaging called out on the package Meet consumers where they are with product and health information, amplifying digital commerce programming Advance opportunities on retailer apps and websites to support these shoppers Acosta Group's "GLP-1 & The Weight Loss Revolution Shopper Insights Study" was conducted Feb
When the growth hormone level rises in your body, it shifts your body into fat-burning mode
The frequency approach also complicates the microdose charts because you need to track both per-injection dose and weekly cumulative dose
Read the Research Characteristics and food consumption for current, previous, and potential consumers of GLP-1s Food Quality and Preference Volume 118, Issue C (2024) About the Researcher Brandon McFadden Professor and the Tyson Endowed Chair in Food Policy Economics Ph.D